Table: Sapporo Clinical Lab -Q1 group results

Sapporo Clinical Laboratory

06/08/2018 07:30

Aug 6 (Reuters)- 
             Sapporo Clinical Laboratory Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Mar 31, 2019 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             4.28                4.38             17.97    
                 (-2.3 pct)          (+3.3 pct)       (+2.9 pct)  
  Operating        95 mln              277 mln            1.04    
                 (-65.5 pct)        (+150.4 pct)      (+2.4 pct)  
  Recurring        107 mln             288 mln            1.06    
                 (-62.7 pct)        (+126.6 pct)      (+0.5 pct)  
  Net              65 mln              192 mln          716 mln   
                 (-65.7 pct)        (+139.9 pct)      (+4.6 pct)  
  EPS             19.04 yen           55.22 yen       207.05 yen  
  Ann Div                             11.00 yen        10.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             11.00 yen        10.00 yen  
  
  NOTE - Sapporo Clinical Laboratory Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=9776.T